Related Experiment Video
Updated: Jun 29, 2026
06:20
Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells (MSCs)
Published on: December 24, 2015
Mesenchymal stromal cells: tissue engineers and immune response modulators
Lieke C J van den Berk1, Carl G Figdor, Ruurd Torensma
1Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Nijmegen, the Netherlands.
Archivum Immunologiae Et Therapiae Experimentalis
|October 7, 2008
Summary
Mesenchymal stromal cells (MSCs) possess immune-suppressive qualities, enabling their use in treating conditions like heart attack and bone regeneration. Notably, MSCs improve survival rates in bone marrow transplant patients by reducing graft-versus-host disease severity.
Area of Science:
- Immunology
- Regenerative Medicine
- Cell Therapy
Background:
- Mesenchymal stromal cells (MSCs) exhibit potent immune-suppressive properties in vitro and in vivo.
- Their immune-stealth characteristics allow for allogeneic transplantation.
- MSCs are explored for treating various diseases, including cardiac repair and bone-cartilage regeneration.
Purpose of the Study:
- To review the literature on mesenchymal stromal cell (MSC) mechanisms.
- To elucidate the mechanisms behind MSCs in clinical treatment modalities.
- To highlight the efficacy of MSCs in graft-versus-host disease and tissue regeneration.
Main Methods:
- Literature review of current scientific publications.
- Analysis of studies detailing MSC immunomodulation.
- Examination of clinical data on MSC-based therapies.
Main Results:
- MSCs demonstrate significant immune suppression, crucial for therapeutic applications.
- Allogeneic MSCs have shown success in treating infarcted heart tissue and promoting bone-cartilage regeneration.
- A remarkable 20-50% increase in two-year survival was observed in bone marrow transplant patients treated with MSCs for graft-versus-host disease.
Conclusions:
- Mesenchymal stromal cells (MSCs) offer promising therapeutic potential due to their immunomodulatory functions.
- MSC therapy is effective in managing graft-versus-host disease and facilitating tissue repair.
- Further research into MSC mechanisms will optimize their clinical application in regenerative medicine and transplantation.
Related Concept Videos
01:19Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...